Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandon Manley

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Cancer Control : Journal of the Moffitt Cancer Center|January 23, 2025
Short- and Intermediate-Term Morbidity Following Total Pelvic Exenteration in Colorectal CancerChristopher Guske, Nusheen Immen, Devon Conant, et al.
Advances in Radiation Oncology|October 21, 2020
Prostatic Artery Embolization Is Safe and Effective for Medically Recalcitrant Radiation-Induced ProstatitisNainesh Parikh, Edward Keshishian, Ayushman Sharma, et al.
JAMA Oncology|August 10, 2023
Immunotherapy in the Treatment of Localized Genitourinary CancersAndrea Necchi, Bishoy M Faltas, Susan F Slovin, et al.
Urologic Oncology|June 11, 2014
Patients with anatomically "simple" renal masses are more likely to be placed on active surveillance than those with anatomically "complex" lesionsJeffrey J Tomaszewski, Robert G Uzzo, Neil Kocher, et al.
JAMA Oncology|September 5, 2018
Downstaging and Survival Outcomes Associated With Neoadjuvant Chemotherapy Regimens Among Patients Treated With Cystectomy for Muscle-Invasive Bladder CancerCharles C Peyton, Dominic Tang, Richard R Reich, et al.
European Urology|September 17, 2025
Feasibility and Functional Reactivity of Expanded Tumor-infiltrating Lymphocytes from Non-clear-cell Renal Cell CarcinomaMarine Potez, Seyed Behzad Jazayeri, Christopher Guske, et al.
Eclinicalmedicine|January 26, 2024
15 years of patient-reported outcomes in clinical trials leading to GU cancer drug approvals: a systematic review on the quality of data reporting and analysisMahati Paravathaneni, Houssein Safa, Vidhu Joshi, et al.
Cancer Medicine|September 28, 2020
Influence of gene expression on survival of clear cell renal cell carcinomaAnders Berglund, Ernest K Amankwah, Young-Chul Kim, et al.
JCO Clinical Cancer Informatics|July 26, 2024
Feasibility of a Smartphone Application for Education and Symptom Management of Patients With Renal Cell Carcinoma on Combined Tyrosine Kinase and Immune Checkpoint InhibitorsGabriel Roman Souza, Kea Turner, Keerthi Gullapalli, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 2, 2024
Pathogenic Roles for RNASET2 in Clear Cell Renal Cell CarcinomaTaylor Peak, Yijun Tian, Aman Patel, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Cancer Control : Journal of the Moffitt Cancer Center|January 23, 2025
Short- and Intermediate-Term Morbidity Following Total Pelvic Exenteration in Colorectal CancerChristopher Guske, Nusheen Immen, Devon Conant, et al.
Advances in Radiation Oncology|October 21, 2020
Prostatic Artery Embolization Is Safe and Effective for Medically Recalcitrant Radiation-Induced ProstatitisNainesh Parikh, Edward Keshishian, Ayushman Sharma, et al.
JAMA Oncology|August 10, 2023
Immunotherapy in the Treatment of Localized Genitourinary CancersAndrea Necchi, Bishoy M Faltas, Susan F Slovin, et al.
Urologic Oncology|June 11, 2014
Patients with anatomically "simple" renal masses are more likely to be placed on active surveillance than those with anatomically "complex" lesionsJeffrey J Tomaszewski, Robert G Uzzo, Neil Kocher, et al.
JAMA Oncology|September 5, 2018
Downstaging and Survival Outcomes Associated With Neoadjuvant Chemotherapy Regimens Among Patients Treated With Cystectomy for Muscle-Invasive Bladder CancerCharles C Peyton, Dominic Tang, Richard R Reich, et al.
European Urology|September 17, 2025
Feasibility and Functional Reactivity of Expanded Tumor-infiltrating Lymphocytes from Non-clear-cell Renal Cell CarcinomaMarine Potez, Seyed Behzad Jazayeri, Christopher Guske, et al.
Eclinicalmedicine|January 26, 2024
15 years of patient-reported outcomes in clinical trials leading to GU cancer drug approvals: a systematic review on the quality of data reporting and analysisMahati Paravathaneni, Houssein Safa, Vidhu Joshi, et al.
Cancer Medicine|September 28, 2020
Influence of gene expression on survival of clear cell renal cell carcinomaAnders Berglund, Ernest K Amankwah, Young-Chul Kim, et al.
JCO Clinical Cancer Informatics|July 26, 2024
Feasibility of a Smartphone Application for Education and Symptom Management of Patients With Renal Cell Carcinoma on Combined Tyrosine Kinase and Immune Checkpoint InhibitorsGabriel Roman Souza, Kea Turner, Keerthi Gullapalli, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 2, 2024
Pathogenic Roles for RNASET2 in Clear Cell Renal Cell CarcinomaTaylor Peak, Yijun Tian, Aman Patel, et al.
Pageof 4